Risk Factors for Photodynamic Therapy of Predominantly Classic Choroidal Neovascularization in Age-related Macular Degeneration

American Journal of Ophthalmology

Volumn 142, Issue 3, 2006, Pages

  Kaiserman, Igor ^a   Kaiserman, Nadia ^b   Elhayany, Asher ^c   Vinker, Shlomo ^c,d  

^a BARZILAI MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; ECONOMIC ASPECT; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RISK FACTOR; SOCIAL STATUS; SUBRETINAL NEOVASCULARIZATION; AGE; HEALTH MAINTENANCE ORGANIZATION; ISRAEL; MIDDLE AGED; PHOTOCHEMOTHERAPY; REGISTER; SEX DIFFERENCE; STATISTICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; ISRAEL; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; REGISTRIES; RISK FACTORS; SEX FACTORS;

EID: 33748857395     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.04.031     Document Type: Article

References (43)

1. Leibowitz H.M., Krueger D.E., Maunder L.R., et al. The Framingham Eye Study monograph. an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 24 (1980) 335-610
2. Klein B.E., and Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 100 (1982) 571-573
3. Klein R., Klein B.E., Jensen S.C., and Meuer S.M. The five-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
4. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
5. Klein R., Wang Q., Klein B.E., et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36 (1995) 182-191
6. Treatment-of-age-related-macular-degeneration-with-photodynamic-therapy -(TAP)-Study-Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 117 (1999) 1329-1345
7. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 108 (2001) 697-704
8. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report No. 3. Ophthalmology 107 (2000) 2224-2232
9. Miyazaki M., Kiyohara Y., Yoshida A., et al. The five-year incidence and risk factors for age-related maculopathy in a general Japanese population. the Hisayama study. Invest Ophthalmol Vis Sci 46 (2005) 1907-1910
10. McCarty C.A., Mukesh B.N., Fu C.L., et al. Risk factors for age-related maculopathy. the Visual Impairment Project. Arch Ophthalmol 119 (2001) 1455-1462
11. Santos L.P., Diniz J.R., Leao A.C., and Sena M.F. Degeneracao macular relacionada a idade. prevalencia e fatores de risco em dois centros oftalmologicos de referencia em Pernambuco. [Age-related macular degeneration: analysis in two ophthalmological centers in Pernambuco-Brazil]. Arq Bras Oftalmol 68 (2005) 229-233
12. Buch H., Vinding T., la Cour M., et al. Risk factors for age-related maculopathy in a 14-year follow-up study. the Copenhagen City Eye Study. Acta Ophthalmol Scand 83 (2005) 409-418
13. Clemons T.E., Milton R.C., Klein R., et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS Report No. 19. Ophthalmology 112 (2005) 533-539
14. Evans J.R., Fletcher A.E., and Wormald R.P. 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 89 (2005) 550-553
15. Tomany S.C., Wang J.J., van Leeuwen R., et al. Risk factors for incident age-related macular degeneration. pooled findings from three continents. Ophthalmology 111 (2004) 1280-1287
16. van Leeuwen R., Ikram M.K., Vingerling J.R., et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy. the Rotterdam Study. Invest Ophthalmol Vis Sci 44 (2003) 3771-3777
17. Chaine G., Hullo A., Sahel J., et al., France-DMLA Study Group. Case-control study of the risk factors for age-related macular degeneration. Br J Ophthalmol 82 (1998) 996-1002
18. Hyman L., Schachat A.P., He Q., Leske M.C., and Age-Related Macular Degeneration Risk Factors Study Group. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 118 (2000) 351-358
19. Wachter A., Sun Y., Dasch B., et al. Munsteraner Altern- und Retinastudie (MARS). Zusammenhang zwischen Risikofaktoren der Arteriosklerose und der altersabhangiger Makuladegeneration. [Munster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration]. Ophthalmologe 101 (2004) 50-53
20. Belda Sanchis J.I., Quijada Gonzalez A., Munoz Ruiz G., et al. Los lipidos sericos, factor de riesgo de la degeneracion macular asociada a la edad? [Are blood lipids a risk factor for age-related macular degeneration?]. Arch Soc Esp Oftalmol 76 (2001) 13-17
21. Schaumberg D.A., Christen W.G., Hankinson S.E., and Glynn R.J. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 119 (2001) 1259-1265
22. Klein B.E., Klein R., Lee K.E., and Jensen S.C. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 8 (2001) 251-262
23. Moeini H.A., Masoudpour H., and Ghanbari H. A study of the relation between body mass index and the incidence of age-related macular degeneration. Br J Ophthalmol 89 (2005) 964-966
24. Delcourt C., Michel F., Colvez A., et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration. the POLA Study. Ophthalmic Epidemiol 8 (2001) 237-249
25. Rennert G., and Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 3 (2001) 404-408
26. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
27. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. JAMA 289 (2003) 2560-2572
28. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe. the SCORE project. Eur Heart J 24 (2003) 987-1003
29. Hyman L.G., Lilienfeld A.M., Ferris III F.L., and Fine S.L. Senile macular degeneration. a case-control study. Am J Epidemiol 118 (1983) 213-227
30. Haddad W.M., Coscas G., and Soubrane G. Eligibility for treatment and angiographic features at the early stage of exudative age-related macular degeneration. Br J Ophthalmol 86 (2002) 663-669
31. Bressler N.M. Age-related macular degeneration. New hope for a common problem comes from photodynamic therapy. BMJ 321 (2000) 1425-1427
32. Javitt J.C., Zhou Z., Maguire M.G., et al. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 110 (2003) 1534-1539
33. Voutilainen Kaunisto R.M., Terasvirta M.E., Uusitupa M.I., and Niskanen L.K. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects. a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care 23 (2000) 1672-1678
34. Mitchell P., and Wang J.J. Diabetes, fasting blood glucose and age-related maculopathy. the Blue Mountains Eye Study. Aust N Z J Ophthalmol 27 (1999) 197-199
35. Klein R., Klein B.E., Jensen S.C., and Moss S.E. The relation of socioeconomic factors to the incidence of early age-related maculopathy. the Beaver Dam Eye Study. Am J Ophthalmol 132 (2001) 128-131
36. Walter-Ginzburg A., Guralnik J.M., Blumstein T., et al. Assistance with personal care activities among the old-old in Israel. a national epidemiological study. J Am Geriatr Soc 49 (2001) 1176-1184
37. Yoshida A., Yoshida M., Yoshida S., et al. Familial cases with age-related macular degeneration. Jpn J Ophthalmol 44 (2000) 290-295
38. Smith W., and Mitchell P. Family history and age-related maculopathy. the Blue Mountains Eye Study. Aust N Z J Ophthalmol 26 (1998) 203-206
39. Grizzard S.W., Arnett D., and Haag S.L. Twin study of age-related macular degeneration. Ophthalmic Epidemiol 10 (2003) 315-322
40. Klaver C.C., Kliffen M., van Duijn C.M., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63 (1998) 200-206
41. Schultz D.W., Weleber R.G., Lawrence G., et al. HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease. review and perspective. Ophthalmic Genet 26 (2005) 101-105
42. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. Cholesterol and age-related macular degeneration. is there a link?. Am J Ophthalmol 137 (2004) 750-752
43. Klein R., Klein B.E., Knudtson M.D., et al. Prevalence of age-related macular degeneration in four racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113 (2006) 373-380